Unsal-Tan O - Search Results

1

Synthesis, molecular docking, and biological evaluation of novel 2-pyrazoline derivatives as multifunctional agents for the treatment of Alzheimer's disease.

Unsal-Tan O, Tüylü Küçükkılınç T, Ayazgök B, Balkan A, Ozadali-Sari K. Unsal-Tan O, et al. Medchemcomm. 2019 May 9;10(6):1018-1026. doi: 10.1039/c9md00030e. eCollection 2019 Jun 1. Medchemcomm. 2019. PMID: 31304000 Free PMC article.

2

Novel multi-targeted agents for Alzheimer's disease: Synthesis, biological evaluation, and molecular modeling of novel 2-[4-(4-substitutedpiperazin-1-yl)phenyl]benzimidazoles.

Ozadali-Sari K, Tüylü Küçükkılınç T, Ayazgok B, Balkan A, Unsal-Tan O. Ozadali-Sari K, et al. Among authors: unsal tan o. Bioorg Chem. 2017 Jun;72:208-214. doi: 10.1016/j.bioorg.2017.04.018. Epub 2017 May 2. Bioorg Chem. 2017. PMID: 28478328

3

Synthesis and cyclooxygenase inhibitory activities of some N-acylhydrazone derivatives of isoxazolo[4,5-d]pyridazin-4(5H)-ones.

Unsal-Tan O, Ozden K, Rauk A, Balkan A. Unsal-Tan O, et al. Eur J Med Chem. 2010 Jun;45(6):2345-52. doi: 10.1016/j.ejmech.2010.02.012. Epub 2010 Feb 10. Eur J Med Chem. 2010. PMID: 20207453

4

Molecular modeling, synthesis and screening of some new 4-thiazolidinone derivatives with promising selective COX-2 inhibitory activity.

Unsal-Tan O, Ozadali K, Piskin K, Balkan A. Unsal-Tan O, et al. Eur J Med Chem. 2012 Nov;57:59-64. doi: 10.1016/j.ejmech.2012.08.046. Epub 2012 Sep 7. Eur J Med Chem. 2012. PMID: 23047224

5

Novel thiazolo[3,2-b]-1,2,4-triazoles derived from naproxen with analgesic/anti-inflammatory properties: Synthesis, biological evaluation and molecular modeling studies.

Sarigol D, Uzgoren-Baran A, Tel BC, Somuncuoglu EI, Kazkayasi I, Ozadali-Sari K, Unsal-Tan O, Okay G, Ertan M, Tozkoparan B. Sarigol D, et al. Among authors: unsal tan o. Bioorg Med Chem. 2015 May 15;23(10):2518-28. doi: 10.1016/j.bmc.2015.03.049. Epub 2015 Mar 27. Bioorg Med Chem. 2015. PMID: 25868745

6

Novel Thiazolidinone-Azole Hybrids: Design, Synthesis and Antimycobacterial Activity Studies.

Eroglu B, Ozadali-Sari K, Unsal-Tan O, Dharmarajan S, Yogeeswari P, Balkan A. Eroglu B, et al. Among authors: unsal tan o. Iran J Pharm Res. 2016 Fall;15(4):783-790. Iran J Pharm Res. 2016. PMID: 28243274 Free PMC article.

7

Some New Hydrazone Derivatives Bearing the 1,2,4-Triazole Moiety as Potential Antimycobacterial Agents.

Özadali Sari K, Ünsal Tan O, Sriram D, Balkan A. Özadali Sari K, et al. Among authors: unsal tan o. Turk J Pharm Sci. 2019 Dec;16(4):432-436. doi: 10.4274/tjps.galenos.2018.43660. Epub 2019 Nov 11. Turk J Pharm Sci. 2019. PMID: 32454746 Free PMC article.

8

Design, Synthesis and Cytotoxic Evaluation of N-Acylhydrazone-Incorporated Isoxazolo[4,5-d]pyridazin-4(5H)-one Derivatives.

Ozadali-Sari K, Ceylan S, Yucel ES, Sabuncuoglu S, Unsal-Tan O. Ozadali-Sari K, et al. Among authors: unsal tan o. Chem Biodivers. 2022 Sep;19(9):e202200389. doi: 10.1002/cbdv.202200389. Epub 2022 Sep 5. Chem Biodivers. 2022. PMID: 35986895

9

Design and synthesis of new 2-oxoquinoxalinyl-1,2,4-triazoles as antitumor VEGFR-2 inhibitors.

Zengin M, Unsal Tan O, Arafa RK, Balkan A. Zengin M, et al. Among authors: unsal tan o. Bioorg Chem. 2022 Apr;121:105696. doi: 10.1016/j.bioorg.2022.105696. Epub 2022 Feb 19. Bioorg Chem. 2022. PMID: 35217379

10

1,2-Diaryl-2-hydroxyiminoethanones as dual COX-1 and β-amyloid aggregation inhibitors: biological evaluation and in silico study.

Irannejad H, Unsal Tan O, Ozadali K, Dadashpour S, Tuylu Kucukkilinc T, Ahangar N, Ahmadnejad M, Emami S. Irannejad H, et al. Chem Biol Drug Des. 2015 Apr;85(4):494-503. doi: 10.1111/cbdd.12435. Epub 2014 Oct 11. Chem Biol Drug Des. 2015. PMID: 25227162

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page